Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand
12:16pm, Friday, 29'th Nov 2024
For my initial coverage of Labcorp, I'm calling it a hold, and an opportunity to earn a $0.72/share quarterly dividend on the leading clinical lab company in the US. The firm shows future growth indic
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
07:52am, Tuesday, 26'th Nov 2024
Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium BOSTON and BURLINGTON, N.C. , Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the develo
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
04:23am, Wednesday, 20'th Nov 2024
Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government
Labcorp CFO Glenn Eisenberg Announces Plans to Retire
07:00am, Tuesday, 19'th Nov 2024
Julia Wang Named Chief Financial Officer Beginning December 2, 2024 BURLINGTON, N.C. , Nov. 19, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory serv
Is Labcorp Stock a Good Pick for Your Portfolio Right Now?
08:36am, Friday, 15'th Nov 2024
Investors are increasingly optimistic about LH due to its partnerships and operational discipline.
Labcorp Adds New Capabilities to Global Trial Connect: Stock to Gain?
09:25am, Wednesday, 13'th Nov 2024
LH launches new enhancements to Global Trial Connect to streamline site workflow.
Labcorp Holdings Inc. (LH) Q3 2024 Earnings Call Transcript
02:00pm, Thursday, 24'th Oct 2024
Labcorp Holdings Inc. (NYSE:LH ) Q3 2024 Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants Christin O'Donnell – Vice President-Investor Relations Adam Schechter – Chairman
LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains
12:16pm, Thursday, 24'th Oct 2024
Labcorp beats on earnings and revenues in the third quarter, entering the fourth half of 2024 with robust momentum.
Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics
11:35am, Thursday, 24'th Oct 2024
The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
11:25am, Thursday, 24'th Oct 2024
Thursday, Laboratory Corp LH reported third-quarter 2024 adjusted earnings per share of $3.50, up from $3.38 a year ago, beating the consensus of $3.49.
Labcorp (LH) Q3 Earnings and Revenues Surpass Estimates
09:01am, Thursday, 24'th Oct 2024
Labcorp (LH) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $3.38 per share a year ago.
Labcorp beats quarterly estimates on diagnostic test demand
07:10am, Thursday, 24'th Oct 2024
Laboratory operator Labcorp on Thursday beat Wall Street estimates for third-quarter profit and revenue, helped by demand for diagnostic tests.
Labcorp Announces 2024 Third Quarter Results
06:50am, Thursday, 24'th Oct 2024
Updates Full-Year Guidance Results from Continuing Operations for third quarter 2024 versus last year: Revenue: $3.28 billion versus $3.06 billion Diluted EPS: $2.00 versus $2.11 Adjusted EPS: $3.50 v
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:21am, Monday, 21'st Oct 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Labcorp (LH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
Labcorp (LH) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Thursday, 17'th Oct 2024
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
